Targeting TLR2/TLR4 Pathways in Periodontitis: Molecular Insights and Emerging Aptamer-Based Therapeutic Strategies
Trends in Immunotherapy · 20.08.2026 · 10 (3) · 46-69
DOI: 10.54963/ti.v10i3.100534 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trends in Immunotherapy, online erschienen am 20.08.2026. Verfasst von Fong Fong Liew und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Periodontitis is a chronic inflammatory disease of the gingival and periodontal tissues, primarily initiated by bacterial accumulation and driven by an excessive host immune response. This persistent inflammatory condition promotes periodontal tissue degradation through the activation of Toll-like receptor 2 (TLR2) and Toll-like receptor 4 (TLR4) signalling pathways, leading to the production of pro-inflammatory mediators, including interleukin-6, interleukin-8 and tumour necrosis factor-alpha. These mediators alter the local inflammatory microenvironment, perpetuate immune activation and contribute to progressive periodontal tissue destruction. This review summarises the roles of TLR2- and TLR4-associated genes, proteins and microRNAs in the pathogenesis of periodontitis, based on reported research findings, STRING protein–protein interaction network analysis, GO/Reactome enrichment analysis and profiling. The study also explores the potential roles of antibodies and aptamers in suppressing inflammation and promoting wound healing. Although antibodies exhibit high target specificity, their complex manufacturing processes, higher costs and potential immunogenicity may limit their clinical applicability compared with aptamers. Aptamers, in contrast, are relatively stable, cost-effective and generally non-immunogenic, making them promising molecular tools for targeted therapeutic intervention. Based on the reviewed findings, aptamers may be further explored as potential therapeutic agents for regulating intracellular signalling pathways associated with TLR2- and TLR4-mediated inflammation. Overall, this review highlights the relationship between molecular mechanisms and therapeutic innovation in periodontitis, particularly through TLR2- and TLR4-associated pathways. It also emphasises the relevance of molecular network analysis, computer-assisted simulation technologies and precision medicine approaches in advancing therapeutic strategies for chronic inflammatory disorders.
Zitieren
APA
Liew, F. F., Azizul, M. A. B., Ng, Y. H., Thiin, N. L. Y. S., & Othman, N. A. B. (2026). Targeting TLR2/TLR4 Pathways in Periodontitis: Molecular Insights and Emerging Aptamer-Based Therapeutic Strategies. Trends in Immunotherapy, 10(3), 46-69. https://doi.org/10.54963/ti.v10i3.100534
Vancouver
Liew FF, Azizul MAB, Ng YH, Thiin NLYS, Othman NAB. Targeting TLR2/TLR4 Pathways in Periodontitis: Molecular Insights and Emerging Aptamer-Based Therapeutic Strategies. Trends in Immunotherapy. 2026;10(3):46-69. doi:10.54963/ti.v10i3.100534
BibTeX
@article{Liew2026,
author = {Liew, Fong Fong and Azizul, Muhammad Aiman Bin and Ng, Yun Han and Thiin, Nydia Lynn Yong Shu and Othman, Nur Alia Binti},
title = {Targeting TLR2/TLR4 Pathways in Periodontitis: Molecular Insights and Emerging Aptamer-Based Therapeutic Strategies},
journal = {Trends in Immunotherapy},
year = {2026},
volume = {10},
number = {3},
pages = {46--69},
doi = {10.54963/ti.v10i3.100534}
}
EUVIMED